Displaying 1421 - 1440 of 4000
It Only Takes Two to Tango: Reflections on Six Months at the FTC
Global Competition Review's Annual Antitrust Law Leaders Forum
Date
By
Bruce Hoffman, Director, Bureau of Competition
File
Concurring Statement of Acting Chairman Maureen K. Ohlhausen
Date
Matter Number
X120042
112 3128
File
Vertical Merger Enforcement at the FTC
Remarks at Credit Suisse 2018 Washington Perspectives Conference
Washington DC
Date
By
Bruce Hoffman, Director, Bureau of Competition
File
UCool Heroes Arena App
Resolution of CARU referral
Date
By
Devin Willis fka Devin Domond, Former Chief of Staff for Advertising Practices
File
Text of the Letter
(1.29 MB)
Why States Should Have Primary Oversight of Attorney’s Activities in Debt-Collection Litigation
InsideARM.com
Date
By
Thomas B. Pahl, Former Acting Director, Bureau of Consumer Protection
Dave & Buster’s
Resolution of CARU referral
Date
By
Devin Willis fka Devin Domond, Former Chief of Staff for Advertising Practices
File
Text of the Letter
(1.59 MB)
Remarks at the FTC Informational Injury Workshop
Washington DC
Date
File
Remarks at the FTC Informational Injury Workshop
(163.16 KB)
The Implications of Algorithmic Pricing for Coordinated Effects Analysis and Price Discrimination Markets in Antitrust Analysis
Antitrust Magazine
Date
By
Terrell McSweeny, Former Commissioner
Putting the FTC Cop Back on the Beat
Remarks at The Future of Internet Freedom
Washington, DC
Date
File
Putting the FTC Cop Back on the Beat
(103.82 KB)
The First Wealth is Health: Protecting Competition in Healthcare Markets
Remarks at the 2017 ABA Fall Forum
Washington, DC
Date
Synergy Pharmaceuticals, Inc. (Trulance prescription drug)
Resolution of NAD referral
Date
By
Devin Willis fka Devin Domond, Former Chief of Staff for Advertising Practices
File
Text of the Letter
(1.41 MB)
GetLitShoes.com (AMILIFE EDC Fidget Spinner & Fidget Spinner EDC Hand Spinner)
Resolution of NAD referral
Date
By
Devin Willis fka Devin Domond, Former Chief of Staff for Advertising Practices
File
Text of the Letter
(220.73 KB)
Remarks of Thomas Pahl, “Reconsidering Advertising Substantiation Forum and Remedy Policies”
2017 ANA/BAA Marketing Law Conference
Chicago, IL
Date
By
Thomas B. Pahl, Former Acting Director, Bureau of Consumer Protection
File
Diagnosing the Treatments: Issues in Post-Patent Pharmaceutical Markets
Opening Remarks from the Federal Trade Commission’s Understanding Competition in Prescription Drug Markets: Entry and Supply Chain Dynamics
Washington, DC
Date
Opening Remarks for the 2017 DSA Fall Conference
Arlington, VA
Date
File
Opening Remarks for the 2017 DSA Fall Conference
(308.82 KB)
Prepared Statement of the Federal Trade Commission On "Net Neutrality and the Role of Antitrust," Before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Judiciary Committee, United States House of Representatives
Congressional Session
115th Congress
Date
Matter Number
P859900
By
Terrell McSweeny, Former Commissioner
File
Text of the Commission Testimony
(22.74 KB)
Related Releases
Prepared Statement of the Federal Trade Commission On "Net Neutrality and the Role of Antitrust," Before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Judiciary Committee, United States House of Representatives
Congressional Session
115th Congress
Date
Matter Number
P859900
By
Terrell McSweeny, Former Commissioner
File
Text of the Commission Testimony
(22.74 KB)
Related Releases
Statement of FTC Acting Chairman Maureen K. Ohlhausen on Net Neutrality and the Role of Antitrust
Hearing Before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the House Judiciary Committee
Washington, DC
Date
Displaying 1421 - 1440 of 4000
Join us at the FTC!